Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2004;90:1211-1213; doi:10.1136/hrt.2003.018226
Copyright © 2004 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2004;90:1211-1213
© 2004 by BMJ Publishing Group & British Cardiac Society

SCIENTIFIC LETTER

Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease

T Amaki1, T Suzuki1, F Nakamura1, D Hayashi1, Y Imai1, H Morita1, K Fukino1, T Nojiri1, S Kitano2, N Hibi2, T Yamazaki1, R Nagai1

1 Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan
2 SRL Inc, Tokyo, Japan

Correspondence to:
Correspondence to:
Dr T Suzuki
Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; torusuzu-tky@umin.ac.jp

Accepted 19 January 2004

Abbreviations: ACS, acute coronary syndromes; CAD, coronary artery disease; HDL, high density lipoprotein; LDL, low density lipoprotein; MDA, malondialdehyde-modified; Ox, oxidative; SVD, single vessel disease; 2VD, two vessel disease; 3VD, three vessel disease

Keywords: oxidised low density lipoprotein; coronary artery disease; risk marker

The first 150 words of the full text of this article appear below.

Oxidatively modified low density lipoprotein (OxLDL) plays an important role in the development of atherosclerosis as its uptake by macrophages and smooth muscle cells leads to formation of foam cells which is a critical step in the evolution of the pathological state.1,2 Circulating OxLDL concentrations may therefore reflect the state of pathological atherosclerosis, and be a possible biochemical risk marker for coronary artery disease (CAD). Numerous efforts have been directed at detecting OxLDL concentrations in the circulation for this reason, but technical difficulties have hampered detection of minute amounts of OxLDL. To overcome these limitations, we focused on circulating malondialdehyde modified LDL (MDA-LDL), a chemical modification thought to reflect naturally occurring oxidation of LDL,3,4 and developed a sensitive immunoassay of circulating MDA-LDL concentrations. The diagnostic performance of MDA-LDL in CAD was compared against known lipid markers. This comparison revealed, for the first time, that MDA-LDL is superior, thus suggesting that . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.